Max Healthcare Institute has informed that the Board of Directors of the Company at their meeting held today i.e., May 28, 2021, approved the following: Audited Financial Results (Standalone and Consolidated) for the quarter and financial year ended March 31, 2021; Appointment of K. Narasimha Murthy (DIN-00023046), an independent director on the Board of the Company, as a director on the Board of Crosslay Remedies, an unlisted material subsidiary of the Company for the financial year 2021-22, in terms of Regulation 24(1) of the Listing Regulations, subject to necessary approvals; etc.
The above information is a part of company’s filings submitted to BSE.
